closely associated with several cardiometabolic complications. The potential anti-
inflammatory role of curcuminoids that have already been reported to reduce hepatic
steatosis, in patients with NAFLD was explored in this study. Methods This double-blind,
randomized placebo-controlled trial was conducted for a period of 8 weeks in patients with
NAFLD. Subjects (n= 55) were randomly allocated to receive either curcuminoids or …